Cargando…

Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery

[Image: see text] The precise size control of the lipid nanoparticle (LNP)-based nanodrug delivery system (DDS) carriers, such as 10 nm size tuning of LNPs, is one major challenge for the development of next-generation nanomedicines. Size-controlled LNPs would realize size-selective tumor targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Niko, Maeki, Masatoshi, Sato, Yusuke, Note, Yusuke, Ishida, Akihiko, Tani, Hirofumi, Harashima, Hideyoshi, Tokeshi, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641893/
https://www.ncbi.nlm.nih.gov/pubmed/31458718
http://dx.doi.org/10.1021/acsomega.8b00341
_version_ 1783436878112882688
author Kimura, Niko
Maeki, Masatoshi
Sato, Yusuke
Note, Yusuke
Ishida, Akihiko
Tani, Hirofumi
Harashima, Hideyoshi
Tokeshi, Manabu
author_facet Kimura, Niko
Maeki, Masatoshi
Sato, Yusuke
Note, Yusuke
Ishida, Akihiko
Tani, Hirofumi
Harashima, Hideyoshi
Tokeshi, Manabu
author_sort Kimura, Niko
collection PubMed
description [Image: see text] The precise size control of the lipid nanoparticle (LNP)-based nanodrug delivery system (DDS) carriers, such as 10 nm size tuning of LNPs, is one major challenge for the development of next-generation nanomedicines. Size-controlled LNPs would realize size-selective tumor targeting and deliver DNA and RNA to target tumor tissues effectively by passing through the stromal cells. Herein, we developed a baffle mixer device named the invasive lipid nanoparticle production device, or iLiNP device for short, which has a simple two-dimensional microchannel and mixer structure, and we achieved the first reported LNP size tuning at 10 nm intervals in the size range from 20 to 100 nm. In comparison with the conventional LNP preparation methods and reported micromixer devices, our iLiNP device showed better LNP size controllability, robustness of device design, and LNP productivity. Furthermore, we prepared 80 nm sized LNPs with encapsulated small interfering RNA (siRNA) using the iLiNP device; these LNPs effectively performed as nano-DDS carriers in an in vivo experiment. We expect iLiNP devices will become novel apparatuses for LNP production in nano-DDS applications.
format Online
Article
Text
id pubmed-6641893
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-66418932019-08-27 Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery Kimura, Niko Maeki, Masatoshi Sato, Yusuke Note, Yusuke Ishida, Akihiko Tani, Hirofumi Harashima, Hideyoshi Tokeshi, Manabu ACS Omega [Image: see text] The precise size control of the lipid nanoparticle (LNP)-based nanodrug delivery system (DDS) carriers, such as 10 nm size tuning of LNPs, is one major challenge for the development of next-generation nanomedicines. Size-controlled LNPs would realize size-selective tumor targeting and deliver DNA and RNA to target tumor tissues effectively by passing through the stromal cells. Herein, we developed a baffle mixer device named the invasive lipid nanoparticle production device, or iLiNP device for short, which has a simple two-dimensional microchannel and mixer structure, and we achieved the first reported LNP size tuning at 10 nm intervals in the size range from 20 to 100 nm. In comparison with the conventional LNP preparation methods and reported micromixer devices, our iLiNP device showed better LNP size controllability, robustness of device design, and LNP productivity. Furthermore, we prepared 80 nm sized LNPs with encapsulated small interfering RNA (siRNA) using the iLiNP device; these LNPs effectively performed as nano-DDS carriers in an in vivo experiment. We expect iLiNP devices will become novel apparatuses for LNP production in nano-DDS applications. American Chemical Society 2018-05-09 /pmc/articles/PMC6641893/ /pubmed/31458718 http://dx.doi.org/10.1021/acsomega.8b00341 Text en Copyright © 2018 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Kimura, Niko
Maeki, Masatoshi
Sato, Yusuke
Note, Yusuke
Ishida, Akihiko
Tani, Hirofumi
Harashima, Hideyoshi
Tokeshi, Manabu
Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery
title Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery
title_full Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery
title_fullStr Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery
title_full_unstemmed Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery
title_short Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery
title_sort development of the ilinp device: fine tuning the lipid nanoparticle size within 10 nm for drug delivery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641893/
https://www.ncbi.nlm.nih.gov/pubmed/31458718
http://dx.doi.org/10.1021/acsomega.8b00341
work_keys_str_mv AT kimuraniko developmentoftheilinpdevicefinetuningthelipidnanoparticlesizewithin10nmfordrugdelivery
AT maekimasatoshi developmentoftheilinpdevicefinetuningthelipidnanoparticlesizewithin10nmfordrugdelivery
AT satoyusuke developmentoftheilinpdevicefinetuningthelipidnanoparticlesizewithin10nmfordrugdelivery
AT noteyusuke developmentoftheilinpdevicefinetuningthelipidnanoparticlesizewithin10nmfordrugdelivery
AT ishidaakihiko developmentoftheilinpdevicefinetuningthelipidnanoparticlesizewithin10nmfordrugdelivery
AT tanihirofumi developmentoftheilinpdevicefinetuningthelipidnanoparticlesizewithin10nmfordrugdelivery
AT harashimahideyoshi developmentoftheilinpdevicefinetuningthelipidnanoparticlesizewithin10nmfordrugdelivery
AT tokeshimanabu developmentoftheilinpdevicefinetuningthelipidnanoparticlesizewithin10nmfordrugdelivery